Drug discovery firm in US office move
Nottingham drug discovery company Sygnature Discovery has moved into a new office in Cambridge, Massachusetts as it looks to make further inroads into the North American market.
The firm’s new office at 245 First Street is near Kendall Square in the heart of the Cambridge-Boston biotech hub, where more than 100 pharma and biotech companies are located.
According to Sygnature’s director of marketing Anders Lindstrom, the company has chosen to move into new premises just a short distance from its previous US office in Harvard ... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...